PT3197431T - Composições de formação de espuma e métodos para a distribuição de um agente activo a uma cavidade corporal - Google Patents

Composições de formação de espuma e métodos para a distribuição de um agente activo a uma cavidade corporal

Info

Publication number
PT3197431T
PT3197431T PT158437236T PT15843723T PT3197431T PT 3197431 T PT3197431 T PT 3197431T PT 158437236 T PT158437236 T PT 158437236T PT 15843723 T PT15843723 T PT 15843723T PT 3197431 T PT3197431 T PT 3197431T
Authority
PT
Portugal
Prior art keywords
delivering
foam
methods
active agent
body cavity
Prior art date
Application number
PT158437236T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Pharmiva Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmiva Ab filed Critical Pharmiva Ab
Publication of PT3197431T publication Critical patent/PT3197431T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT158437236T 2014-09-25 2015-09-25 Composições de formação de espuma e métodos para a distribuição de um agente activo a uma cavidade corporal PT3197431T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462055001P 2014-09-25 2014-09-25

Publications (1)

Publication Number Publication Date
PT3197431T true PT3197431T (pt) 2023-05-10

Family

ID=55581573

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158437236T PT3197431T (pt) 2014-09-25 2015-09-25 Composições de formação de espuma e métodos para a distribuição de um agente activo a uma cavidade corporal

Country Status (16)

Country Link
US (1) US9895311B2 (cg-RX-API-DMAC7.html)
EP (2) EP4218803A3 (cg-RX-API-DMAC7.html)
JP (1) JP6659674B2 (cg-RX-API-DMAC7.html)
KR (1) KR102569954B1 (cg-RX-API-DMAC7.html)
CN (1) CN106687109B (cg-RX-API-DMAC7.html)
AU (1) AU2015322112B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017006154B1 (cg-RX-API-DMAC7.html)
CA (1) CA2959717C (cg-RX-API-DMAC7.html)
DK (1) DK3197431T3 (cg-RX-API-DMAC7.html)
ES (1) ES2946510T3 (cg-RX-API-DMAC7.html)
FI (1) FI3197431T3 (cg-RX-API-DMAC7.html)
HU (1) HUE062224T2 (cg-RX-API-DMAC7.html)
PL (1) PL3197431T3 (cg-RX-API-DMAC7.html)
PT (1) PT3197431T (cg-RX-API-DMAC7.html)
RU (1) RU2710019C2 (cg-RX-API-DMAC7.html)
WO (1) WO2016048230A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity
EP3481401A4 (en) * 2016-07-11 2020-03-11 Hennepin Life Sciences, LLC COMPOSITIONS FOR SEXUALLY TRANSMITTED DISEASES
AU2018272880B2 (en) * 2017-05-23 2024-02-29 Pharmiva Ab Foam-forming compositions for delivering an active to a body cavity
BR112023015156A2 (pt) 2021-01-27 2024-01-16 Pharmiva Ab Composição para uso na degradação ou prevenção da formação de biofilme
EP4351506A4 (en) * 2021-06-11 2025-04-23 Ankh Life Sciences Limited Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684479A (en) 1985-08-14 1987-08-04 Arrigo Joseph S D Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures
SE454397B (sv) * 1985-12-20 1988-05-02 Biogram Ab Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur
JPH06279228A (ja) 1993-03-30 1994-10-04 Kao Corp 発泡性組成物
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JPH07197083A (ja) 1993-12-28 1995-08-01 Kao Corp 洗浄剤組成物
US5741525A (en) 1995-10-24 1998-04-21 Marshall University Research Corporation Vaginal pharmaceutical hydrogen peroxide composition
US5778886A (en) 1996-02-27 1998-07-14 Shihata; Alfred Vaginal compositions combining a spermicidal agent and a peroxygen compound
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020031556A1 (en) * 2000-07-21 2002-03-14 Lindahl Ake R. Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition
US7709026B2 (en) 2001-10-29 2010-05-04 Columbia Laboratories, Inc. Low concentration of peroxide for treating or preventing vaginal infections
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
JP4828404B2 (ja) 2003-01-24 2011-11-30 ステフェル リサーチ オーストラリア プロプライエタリー リミティッド リン酸クリンダマイシン発泡体
US8193244B1 (en) 2008-05-29 2012-06-05 Nevada Naturals, Inc. Antimicrobial agents
US20040197270A1 (en) * 2003-04-01 2004-10-07 Mundschenk David D. Topical formulations and delivery systems
KR20060113657A (ko) * 2003-08-25 2006-11-02 포믹스 리미티드 침투성 약제용 거품제
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2006131784A1 (en) 2004-04-28 2006-12-14 Foamix Ltd. Body cavity foams
EP1858506A2 (en) 2005-03-10 2007-11-28 3M Innovative Properties Company Methods of treating ear infections
US20070299043A1 (en) * 2005-10-03 2007-12-27 Hunter William L Anti-scarring drug combinations and use thereof
US20080299520A1 (en) * 2005-12-29 2008-12-04 Ali Mahfuza B Foamable Dental Compositions and Methods
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008110872A2 (en) 2006-06-23 2008-09-18 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
BRPI0809330B8 (pt) * 2007-03-30 2021-05-25 Laccure Ab uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica
RS52337B (sr) * 2007-06-19 2012-12-31 Neubourg Skin Care Gmbh & Co. Kg Dms kreme na bazi pene
US20090239954A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Phosphate buffered ophthalmic solutions displaying improved efficacy
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US8414868B2 (en) * 2010-02-04 2013-04-09 Ultradent Products, Inc. In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions
CN105338963A (zh) * 2013-04-26 2016-02-17 贝欧格兰公司 用于减少痂形成并促进愈合的组合物
US9895311B2 (en) * 2014-09-25 2018-02-20 Pharmiva Ab Foam-forming compositions and methods for delivering an active to a body cavity

Also Published As

Publication number Publication date
CA2959717C (en) 2022-10-18
EP4218803A2 (en) 2023-08-02
US20160089333A1 (en) 2016-03-31
HUE062224T2 (hu) 2023-10-28
KR20170059000A (ko) 2017-05-29
RU2710019C2 (ru) 2019-12-24
WO2016048230A1 (en) 2016-03-31
JP6659674B2 (ja) 2020-03-04
AU2015322112A1 (en) 2017-03-30
PL3197431T3 (pl) 2023-06-19
FI3197431T3 (fi) 2023-05-11
EP3197431A1 (en) 2017-08-02
AU2015322112B2 (en) 2020-10-22
CA2959717A1 (en) 2016-03-31
CN106687109B (zh) 2020-10-23
KR102569954B1 (ko) 2023-08-22
RU2017112055A3 (cg-RX-API-DMAC7.html) 2019-03-25
CN106687109A (zh) 2017-05-17
EP4218803A3 (en) 2023-11-01
BR112017006154A2 (en) 2018-02-06
US9895311B2 (en) 2018-02-20
BR112017006154B1 (pt) 2024-01-23
EP3197431B1 (en) 2023-03-08
RU2017112055A (ru) 2018-10-25
JP2017529377A (ja) 2017-10-05
ES2946510T3 (es) 2023-07-20
DK3197431T3 (da) 2023-06-06
EP3197431A4 (en) 2018-04-04

Similar Documents

Publication Publication Date Title
IL257318A (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
ZA201606646B (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
GB201600635D0 (en) Anchor for inplantation in body tissue
PL3273942T3 (pl) Plaster mikroigłowy do dostarczania składnika aktywnego do skóry
EP3215204A4 (en) Device and method for aerosolized delivering of substance to a natural orifice of the body
IL247795B (en) tco couplings and methods for shipping medical materials
SG11201610699XA (en) Manufacture and cryopreservation of fucosylated cells for therapeutic use
IL242545B (en) Compositions and methods for administering hydrophobic active substances
PL3234107T3 (pl) Limfocyty b do dostarczania in vivo środków terapeutycznych
ZA201601146B (en) Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
PL3104838T3 (pl) Terapeutyczne nanocząstki zawierające środki terapeutyczne oraz ich sposoby wytwarzania i zastosowanie
IL249058A0 (en) Improved forms of selective pi3k delta inhibitors for use in pharmaceutical formulations
EP3125944A4 (en) Methods and compositions for administering an active agent to the pleura of a patient
IL259047A (en) Nanoparticles containing a therapeutic substance, a process for their preparation and uses
HUE062224T2 (hu) Habképzõ kompozíciók és eljárások hatóanyag eljuttatására egy testüregbe
EP3223793A4 (en) Compositions and methods for delivering a bio-active agent or bio-active agents
IL248621B (en) Formulations and methods for vaginal administration of antiprogestins
ZA201907825B (en) Foam-forming compositions for delivering an active to a body cavity
PL2921420T3 (pl) Pojemnik na środek czynny i sposób jego wytwarzania
GB201518078D0 (en) Model generation for drug determination
HK1241307A1 (en) Devices and methods for delivering a beneficial agent to a user
GB201400270D0 (en) Injectable active ingredient release compositions and methods for their production and use
GB201300437D0 (en) Injectable Active Ingredient Release Compositions and Methods for Their Production and Use
GB201408831D0 (en) Foamable formulation